MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
SCYX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

SCYNEXIS (SCYX) Ownership - Who owns SCYNEXIS?

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Other
Address
1 Evertrust Plaza
Phone
+1 201 884-5485
Employees
18
Web
https://www.scynexis.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
40.42M
P/E Ratio
0.91
Total Cash
59.26M
Projected Growth
N/A
Total Debt
2.06M
Revenue
20.34M
Risk (Beta)
-0.00
Dividend Yield
N/A
Total Cash/Share
5.97
Total Debt/Equity
N/A
Revenue/Share
3.23 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SCYX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for SCYX
A.I. Advisor
published General Information

General Information

a company which engages in discovery, development and commercialization of novel anti infectives

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Pharmaceuticals Other
Address
1 Evertrust Plaza
Phone
+1 201 884-5485
Employees
18
Web
https://www.scynexis.com